Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nikkho is a prominent Brazilian pharmaceutical company that has been a subsidiary of Biolab Farmacêutica since its acquisition in 2010. The company specializes in the development, manufacturing, and commercialization of a diverse portfolio of medications, with a particular strength in respiratory health, pediatrics, and primary care. Its product line includes well-established brands such as Transpulmin and Kaloba, which are widely recognized in the Brazilian healthcare market. Operating under the Biolab group, Nikkho leverages extensive regional distribution networks and modern manufacturing facilities to provide accessible therapeutic solutions. The company continues to be a key player in the Brazilian retail pharmacy sector, focusing on high-demand therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nikkho.